Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.

Antiphospholipid antibodies are strongly associated with arterial and venous thrombosis and with fetal loss. Recently an experimental model for antiphospholipid syndrome (APLS) was established in our laboratory. In this model, mice are immunized passively or actively with anticardiolipin antibodies...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	J Clin Invest
Principais autores:	Fishman, P, Falach-Vaknine, E, Zigelman, R, Bakimer, R, Sredni, B, Djaldetti, M, Shoenfeld, Y
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Clinical Investigation 1993
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC288166/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8473523/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116396
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!